文献速递耳科与耳神经

美国国防部突发性感音神经性听力损失的临床实践指南依从性分析

Sudden Sensorineural Hearing Loss in the Department of Defense.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-04-10

该研究回顾性分析了国防部电子病历中204例突发性感音神经性听力损失患者,评估其对该病临床实践指南的依从性。结果显示从症状出现到耳鼻喉科和听力评估的平均时间分别为15.26天和14.16天,口服类固醇使用率67.2%,其中78.8%剂量推荐,鼓室内类固醇使用率31.9%但剂量不一。研究指出需改进早期识别、快速转诊、减少不必要检查及规范类固醇剂量。

要点

  • 从症状出现到耳鼻喉科评估平均延迟15.26天,需加快转诊。
  • 口服类固醇使用率67.2%,其中78.8%采用推荐剂量。
  • 鼓室内类固醇使用率31.9%,但剂量方案不一致。

核心结论

  • 国防部医疗系统在突发性感音神经性听力损失管理中对指南的依从性存在改进空间,尤其是及时转诊和规范类固醇剂量。

研究设计与样本

  • 病例系列研究,回顾性图表审查,纳入2012年3月1日至2015年9月30日期间在国防部电子病历中治疗的204例突发性感音神经性听力损失患者。

主要发现

  • 从症状出现到初级保健或急诊评估的平均间隔为4.86天(95%CI,3.46-6.26)。
  • 从就诊到耳鼻喉科和听力评估的时间分别为15.26天(95%CI,12.34-18.20)和14.16天(95%CI,11.31-17.01)。
  • 诊断检查包括磁共振成像(n=150,73.5%)、计算机断层扫描(n=28,13.7%)和实验室检测(n=50,24.5%)。
  • 口服类固醇用于137例(67.2%)患者,其中78.8%接受了推荐剂量。
  • 鼓室内类固醇用于65例(31.9%)患者,剂量方案不一。

关键数值与推荐

  • 口服类固醇使用率67.2%,其中78.8%符合推荐剂量。
  • 鼓室内类固醇使用率31.9%,但剂量方案不统一。

临床怎么用

  • 应提高对突发性感音神经性听力损失的早期识别并快速转诊至耳鼻喉科和听力部门。
  • 需减少不必要的影像学检查、实验室检测和药物治疗,并规范口服及鼓室内类固醇的剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective The American Academy of Otolaryngology-Head and Neck Surgery Foundation clinical practice guideline (CPG) proposes recommendations regarding sudden sensorineural hearing loss (SSNHL). SSNHL is managed by primary care, emergency medicine, and otolaryngology providers in the Department of Defense (DoD). However, their adherence to this CPG is unknown. We sought to determine provider compliance and identify areas for improvement. Study Design Case series with chart review. Setting DoD's electronic medical record. Subjects and Methods Patients with SSNHL (N = 204) were treated between March 1, 2012, and September 30, 2015. Time from onset of symptoms to evaluation by primary care, emergency department, audiology, and otolaryngology providers and treatments were analyzed. Results The average interval from onset of symptoms to evaluation by a primary care or emergency department provider was 4.86 days (95% CI, 3.46-6.26). Time from presentation to ear, nose, and throat and audiologic evaluation was 15.26 days (95% CI, 12.34-18.20) and 14.16 days (95% CI, 11.31-17.01), respectively. Diagnostic workup included magnetic resonance imaging (n = 150, 73.5%), computed tomography (n = 28, 13.7%), and laboratory testing (n = 50, 24.5%). Oral steroids were used in 137 (67.2%) patients, with 78.8% treated with the recommended dose. Intratympanic steroids were utilized in 65 (31.9%) patients, with variable dosing. Conclusion The DoD is uniquely positioned to evaluate adherence to CPGs on national and international levels given the robust and standardized electronic medical record. Areas of improvement include timely identification of SSNHL with rapid referral to ear, nose, and throat and audiology providers; minimizing unnecessary imaging, laboratory testing, and medications; and correct dosing of oral and intratympanic steroids.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Hughes CK, Fischer J, Esquivel CR, et al. Sudden Sensorineural Hearing Loss in the Department of Defense. Otolaryngol Head Neck Surg. 2018. PMID: 29631507. doi:10.1177/0194599818768511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。